PL186804B1 - Nowy 20-epi analog witaminy D, sposób wytwarzania20-epi analogu witaminy D, kompozycja farmaceutyczna i zastosowanie 20-epi analogu witaminy D - Google Patents

Nowy 20-epi analog witaminy D, sposób wytwarzania20-epi analogu witaminy D, kompozycja farmaceutyczna i zastosowanie 20-epi analogu witaminy D

Info

Publication number
PL186804B1
PL186804B1 PL97329941A PL32994197A PL186804B1 PL 186804 B1 PL186804 B1 PL 186804B1 PL 97329941 A PL97329941 A PL 97329941A PL 32994197 A PL32994197 A PL 32994197A PL 186804 B1 PL186804 B1 PL 186804B1
Authority
PL
Poland
Prior art keywords
compound
formula
compounds
vitamin
ether
Prior art date
Application number
PL97329941A
Other languages
English (en)
Polish (pl)
Other versions
PL329941A1 (en
Inventor
Claus A. S. Bretting
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PL329941A1 publication Critical patent/PL329941A1/xx
Publication of PL186804B1 publication Critical patent/PL186804B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
PL97329941A 1996-06-04 1997-05-15 Nowy 20-epi analog witaminy D, sposób wytwarzania20-epi analogu witaminy D, kompozycja farmaceutyczna i zastosowanie 20-epi analogu witaminy D PL186804B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611603.3A GB9611603D0 (en) 1996-06-04 1996-06-04 Chemical compounds
PCT/DK1997/000225 WO1997046522A1 (en) 1996-06-04 1997-05-15 Novel vitamin d analogues

Publications (2)

Publication Number Publication Date
PL329941A1 PL329941A1 (en) 1999-04-26
PL186804B1 true PL186804B1 (pl) 2004-02-27

Family

ID=10794707

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97329941A PL186804B1 (pl) 1996-06-04 1997-05-15 Nowy 20-epi analog witaminy D, sposób wytwarzania20-epi analogu witaminy D, kompozycja farmaceutyczna i zastosowanie 20-epi analogu witaminy D

Country Status (17)

Country Link
US (1) US6197982B1 (enExample)
EP (1) EP0906276B1 (enExample)
JP (1) JP2000511894A (enExample)
CN (1) CN1217926C (enExample)
AT (1) ATE221875T1 (enExample)
AU (1) AU714223B2 (enExample)
CZ (1) CZ296255B6 (enExample)
DE (1) DE69714590T2 (enExample)
DK (1) DK0906276T3 (enExample)
ES (1) ES2179343T3 (enExample)
GB (1) GB9611603D0 (enExample)
NZ (1) NZ332237A (enExample)
PL (1) PL186804B1 (enExample)
PT (1) PT906276E (enExample)
RO (1) RO120133B1 (enExample)
RU (1) RU2165413C2 (enExample)
WO (1) WO1997046522A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
KR20110113664A (ko) * 2006-08-29 2011-10-17 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
AU2010208323B2 (en) 2009-01-27 2016-03-10 Berg Llc Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy
EP2464357B1 (en) 2009-08-14 2019-05-22 Berg LLC Vitamin d3 and analogs thereof for treating alopecia
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
CN102770121B (zh) * 2009-12-22 2014-10-15 利奥制药有限公司 包含溶剂混合物和维生素d衍生物或类似物的药物组合物
PT2360145E (pt) * 2010-01-26 2012-06-27 Hybrigenics Sa Novo processo para isomerização de estruturas bicíclicas condensadas e preparação de análogos de vitamina d que as contêm
HUE025554T2 (en) * 2010-10-25 2016-02-29 Teijin Pharma Ltd Vitamin D3-23-in derivative
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
AU2016234990B2 (en) 2015-10-02 2018-12-06 Lg Electronics Inc. Washing machine and method for controlling the same
AU2016234988B2 (en) 2015-10-02 2018-08-02 Lg Electronics Inc. Washing machine
US20170096769A1 (en) 2015-10-02 2017-04-06 Lg Electronics Inc. Method for controlling washing machine
US12351551B2 (en) * 2019-11-27 2025-07-08 Yonsung Fine Chemical Co., Ltd. Method for producing maxacalcitol, and intermediate therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU688125A3 (ru) * 1974-12-09 1979-09-25 Тейдзин Лимитед (Фирма) Способ получени 1 , 24/ /диокси-холекальциферола или 1 , 24 / /-диоксихолекальциферола или их производных
EP0296800B1 (en) 1987-06-23 1991-10-16 Yamanouchi Pharmaceutical Co. Ltd. Vitamin d3 derivatives
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9223061D0 (en) 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds

Also Published As

Publication number Publication date
EP0906276B1 (en) 2002-08-07
PL329941A1 (en) 1999-04-26
RU2165413C2 (ru) 2001-04-20
GB9611603D0 (en) 1996-08-07
CN1217926C (zh) 2005-09-07
RO120133B1 (ro) 2005-09-30
EP0906276A1 (en) 1999-04-07
WO1997046522A1 (en) 1997-12-11
DE69714590T2 (de) 2003-04-24
AU714223B2 (en) 1999-12-23
CZ296255B6 (cs) 2006-02-15
AU3025697A (en) 1998-01-05
ES2179343T3 (es) 2003-01-16
ATE221875T1 (de) 2002-08-15
CZ397198A3 (cs) 1999-03-17
JP2000511894A (ja) 2000-09-12
DE69714590D1 (de) 2002-09-12
CN1219928A (zh) 1999-06-16
DK0906276T3 (da) 2002-12-02
HK1019733A1 (en) 2000-02-25
PT906276E (pt) 2002-12-31
NZ332237A (en) 2000-07-28
US6197982B1 (en) 2001-03-06

Similar Documents

Publication Publication Date Title
CA1340614C (en) Cyclopentano-vitamin d analogs
EP1745787B1 (en) NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha 25-DIHYDROXY VITAMIN D3
CA1340615C (en) Compouds effective in inducing cell differentiation and process for preparing same
EP0906276B1 (en) Novel vitamin d analogues
CZ372692A3 (en) Novel analogs of vitamin d, process of their preparation and medicaments based thereon
JP2007502832A (ja) ２−メチレン−１９−ノル−ビタミンｄ２化合物
PL192660B1 (pl) Nowe analogi witaminy D, kompozycja farmaceutyczna zawierająca nowe analogi i ich zastosowanie
WO1989010352A1 (en) SIDE CHAIN UNSATURATED 1alpha-HYDROXYVITAMIN D HOMOLOGS
CA2588417C (en) 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
EP0944592B1 (en) Vitamin d3 derivatives
KR100494205B1 (ko) 신규한비타민d동족체
US20060223782A1 (en) 2-Methylene-19-nor-(23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone
CA2254806A1 (en) Novel vitamin d analogues
Sicinski et al. An analog of 1α, 25-dihydroxy-19-norvitamin D3 with the 1α-hydroxy group fixed in the axial position lacks biological activity in vitro
WO1996030338A1 (en) 1-substituted vitamin d3 analogues
HK1100066B (en) Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy vitamin d3
NZ570712A (en) 2-methylene-1alpha-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
HK1100066A (en) Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy vitamin d3

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130515